LabGenomics Signs Oral Microbiome Microbial Testing Agreement with BankSalad

Genome molecular diagnostics specialist LabGenomics announced on the 4th that it will launch an oral microbiome microorganism testing service in collaboration with BankSalad. Following the supply of DTC genetic testing through BankSalad in November last year, LabGenomics is receiving significant attention from consumers and market stakeholders by releasing this new oral microbiome microorganism test.

Last year, LabGenomics started offering a DTC personal genetic trait test through BankSalad, which analyzes 63 genetic traits related to hair loss, obesity, blood sugar, skin, and more. This service has attracted high interest from both the MZ generation and older generations.

Building on the early success of the DTC test, the newly launched oral microbiome microorganism test provides results for 19 items, including the presence of oral diseases and the likelihood of major diseases influenced by detected harmful bacteria through oral microorganism analysis. It can also detect microorganisms associated with diseases and metabolic disorders such as bad breath, diabetes, dementia, and obesity. It is expected that over 200,000 consumers will use this service annually.

Additionally, the oral microbiome microorganism test offers the advantage of allowing test subjects to manage their internal microorganism data through periodic testing. This enables individuals to directly experience the improvement process of their internal microbiome status and enjoy the engaging aspect of managing their health data independently.

A LabGenomics representative stated, “The oral microbiome microorganism test encourages customers to undergo periodic and repeated testing, allowing them to check how their internal microbiome microorganism status positively changes in as short as one-week intervals. Starting with the launch of the oral microbiome microorganism test on BankSalad, we plan to expand supply to related medical institutions such as dental hospitals and screening centers nationwide.”

They added, “We also plan to actively collaborate with digital healthcare platform companies and continuously add new tests.”

This content was produced with the assistance of AI translation services.